To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Postoperative Antiosteoporotic Treatment with Zoledronic Acid vs Control in Post Menopausal Women

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2025

Postoperative Antiosteoporotic Treatment with Zoledronic Acid vs Control in Post Menopausal Women

Vol: 307| Issue: 1| Number:65| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Postoperative Antiosteoporotic Treatment with Zoledronic Acid Improves Rotator Cuff Healing but Does Not Improve Outcomes in Female Patients with Postmenopausal Osteoporosis: A Prospective, Single-Blinded, Randomized Study.

Arthroscopy . 2024 Mar;40(3):714-722.

Contributing Authors:
M Lei Z Zhu X Hu D Wu W Huang Y Zhang H Chen

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and twenty-four postmenopausal women with osteoporosis undergoing arthroscopic rotator cuff repair were randomized to receive zoledronic acid (n=61) or no antiosteoporotic treatment (n=63). The primary outcome was tendon healing, assessed by ultrasonography, while secondary outcomes included the ASES score, WORC index, and NRS for pain. Outcomes were measured at 6 weeks and 24 months p...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue